133 related articles for article (PubMed ID: 29774408)
1. Possible association of CAG repeat polymorphism in KCNN3 encoding the potassium channel SK3 with oxaliplatin-induced neurotoxicity.
Anon B; Largeau B; Girault A; Chantome A; Caulet M; Perray C; Moussata D; Vandier C; Barin-Le Guellec C; Lecomte T
Cancer Chemother Pharmacol; 2018 Jul; 82(1):149-157. PubMed ID: 29774408
[TBL] [Abstract][Full Text] [Related]
2. Liability of the voltage-gated potassium channel KCNN3 repeat polymorphism to acute oxaliplatin-induced peripheral neurotoxicity.
Argyriou AA; Antonacopoulou AG; Alberti P; Briani C; Bruna J; Velasco R; Anastopoulou GG; Park SB; Cavaletti G; Kalofonos HP
J Peripher Nerv Syst; 2019 Dec; 24(4):298-303. PubMed ID: 31486252
[TBL] [Abstract][Full Text] [Related]
3. SK3 Gene Polymorphism Is Associated with Taxane Neurotoxicity and Cell Calcium Homeostasis.
Rua C; Guéguinou M; Soubai I; Viel E; Potier-Cartereau M; Chantome A; Barbe C; Bougnoux P; Barin-Le Guellec C; Vandier C
Clin Cancer Res; 2018 Nov; 24(21):5313-5320. PubMed ID: 30037821
[No Abstract] [Full Text] [Related]
4. A CAG repeat polymorphism of KCNN3 predicts SK3 channel function and cognitive performance in schizophrenia.
Grube S; Gerchen MF; Adamcio B; Pardo LA; Martin S; Malzahn D; Papiol S; Begemann M; Ribbe K; Friedrichs H; Radyushkin KA; Müller M; Benseler F; Riggert J; Falkai P; Bickeböller H; Nave KA; Brose N; Stühmer W; Ehrenreich H
EMBO Mol Med; 2011 Jun; 3(6):309-19. PubMed ID: 21433290
[TBL] [Abstract][Full Text] [Related]
5. Genetic association study of a polymorphic CAG repeats array of calcium-activated potassium channel (KCNN3) gene and schizophrenia among the Chinese population from Taiwan.
Tsai MT; Shaw CK; Hsiao KJ; Chen CH
Mol Psychiatry; 1999 May; 4(3):271-3. PubMed ID: 10395218
[TBL] [Abstract][Full Text] [Related]
6. Schizophrenia and polymorphic CAG repeats array of calcium-activated potassium channel (KCNN3) gene in Serbian population.
Ivković M; Ranković V; Tarasjev A; Orolicki S; Damjanović A; Paunović VR; Romac S
Int J Neurosci; 2006 Feb; 116(2):157-64. PubMed ID: 16393881
[TBL] [Abstract][Full Text] [Related]
7. Association analysis of a highly polymorphic CAG Repeat in the human potassium channel gene KCNN3 and migraine susceptibility.
Curtain R; Sundholm J; Lea R; Ovcaric M; MacMillan J; Griffiths L
BMC Med Genet; 2005 Sep; 6():32. PubMed ID: 16162291
[TBL] [Abstract][Full Text] [Related]
8. Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: results from a prospective multicenter study.
Argyriou AA; Cavaletti G; Antonacopoulou A; Genazzani AA; Briani C; Bruna J; Terrazzino S; Velasco R; Alberti P; Campagnolo M; Lonardi S; Cortinovis D; Cazzaniga M; Santos C; Psaromyalou A; Angelopoulou A; Kalofonos HP
Cancer; 2013 Oct; 119(19):3570-7. PubMed ID: 23821303
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity.
Basso M; Modoni A; Spada D; Cassano A; Schinzari G; Lo Monaco M; Quaranta D; Tonali PA; Barone C
Cancer Chemother Pharmacol; 2011 May; 67(5):1179-87. PubMed ID: 20872144
[TBL] [Abstract][Full Text] [Related]
10. CAG-repeat length in exon 1 of KCNN3 does not influence risk for schizophrenia or bipolar disorder: a meta-analysis of association studies.
Glatt SJ; Faraone SV; Tsuang MT
Am J Med Genet B Neuropsychiatr Genet; 2003 Aug; 121B(1):14-20. PubMed ID: 12898569
[TBL] [Abstract][Full Text] [Related]
11. CAG repeat polymorphism within the KCNN3 gene is a significant contributor to susceptibility to anorexia nervosa: a case-control study of female patients and several ethnic groups in the Israeli Jewish population.
Koronyo-Hamaoui M; Gak E; Stein D; Frisch A; Danziger Y; Leor S; Michaelovsky E; Laufer N; Carel C; Fennig S; Mimouni M; Apter A; Goldman B; Barkai G; Weizman A
Am J Med Genet B Neuropsychiatr Genet; 2004 Nov; 131B(1):76-80. PubMed ID: 15389773
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Exercise Rehabilitation Program in Relieving Oxaliplatin Induced Peripheral Neurotoxicity.
Gui Q; Li D; Zhuge Y; Xu C
Asian Pac J Cancer Prev; 2021 Mar; 22(3):705-709. PubMed ID: 33773532
[TBL] [Abstract][Full Text] [Related]
13. [Reduction of oxaliplatin-related neurotoxicity by calcium and magnesium infusions].
Muto O; Ando H; Ono T; Itagaki H; Kobayashi Y; Onuki M; Akashi T; Tanaka Y; Hanaoka T
Gan To Kagaku Ryoho; 2007 Apr; 34(4):579-81. PubMed ID: 17431344
[TBL] [Abstract][Full Text] [Related]
14. No evidence for involvement of KCNN3 (hSKCa3) potassium channel gene in familial and isolated cases of schizophrenia.
Bonnet-Brilhault F; Laurent C; Campion D; Thibaut F; Lafargue C; Charbonnier F; Deleuze JF; Ménard JF; Jay M; Petit M; Frebourg T; Mallet J
Eur J Hum Genet; 1999; 7(2):247-50. PubMed ID: 10196711
[TBL] [Abstract][Full Text] [Related]
15. Gain-of-Function Mutations in KCNN3 Encoding the Small-Conductance Ca
Bauer CK; Schneeberger PE; Kortüm F; Altmüller J; Santos-Simarro F; Baker L; Keller-Ramey J; White SM; Campeau PM; Gripp KW; Kutsche K
Am J Hum Genet; 2019 Jun; 104(6):1139-1157. PubMed ID: 31155282
[TBL] [Abstract][Full Text] [Related]
16. Effects of Goshajinkigan (TJ-107) for oxaliplatin-induced peripheral neurotoxicity using the functional assessment of cancer therapy/gynecologic oncology group 12-item neurotoxicity questionnaire in a Phase II, multicenter, randomized, double-blind, placebo-controlled trial.
Aoyama T; Morita S; Kono T; Hata T; Mishima H; Sakamoto J
J Cancer Res Ther; 2021; 17(6):1473-1478. PubMed ID: 34916380
[TBL] [Abstract][Full Text] [Related]
17. Association study of CAG repeats in the KCNN3 gene in Israeli patients with major psychosis.
Ritsner M; Amir S; Koronyo-Hamaoui M; Gak E; Ziv H; Halperin T; Kitain L; Navon R
Psychiatr Genet; 2003 Sep; 13(3):143-50. PubMed ID: 12960745
[TBL] [Abstract][Full Text] [Related]
18. The contribution of SK3 polymorphisms to acute oxaliplatin-induced neurotoxicity: direct or indirect effects?
Park SB; Lin CS; Krishnan AV; Kiernan MC
Cancer Chemother Pharmacol; 2011 May; 67(5):1189-90; author reply 1191-2. PubMed ID: 21327679
[No Abstract] [Full Text] [Related]
19. Association and linkage studies between bipolar affective disorder and the polymorphic CAG/CTG repeat loci ERDA1, SEF2-1B, MAB21L and KCNN3.
Meira-Lima IV; Zhao J; Sham P; Pereira AC; Krieger JE; Vallada H
Mol Psychiatry; 2001 Sep; 6(5):565-9. PubMed ID: 11526470
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study.
Tsuruta A; Yamashita K; Tanioka H; Tsuji A; Inukai M; Yamakawa T; Yamatsuji T; Yoshimitsu M; Toyota K; Yamano T; Nagasaka T; Okajima M
Drug Des Devel Ther; 2016; 10():3827-3835. PubMed ID: 27920498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
